Skip to main content
SpringerLink
Log in

A case of successful percutaneous transluminal septal myocardial ablation for heart failure due to severe left ventricular outflow obstruction with Mönckeberg’s arteriosclerosis, manifested after aortic valvular replacement

  • Case Report
  • Published:
Cardiovascular Intervention and Therapeutics Aims and scope Submit manuscript

Abstract

Although percutaneous transluminal septal myocardial ablation (PTSMA) has been the established treatment of symptomatic patients with hypertrophic obstructive cardiomyopathy (HOCM), the efficacy for specific HOCM is not elucidated. We report a successful case of PTSMA for heart failure with severe left ventricular outflow tract (LVOT) obstruction due to sigmoid-shaped interventricular septum and diffuse left ventricular hypertrophy with Mönckeberg’s arteriosclerosis and aortic valvular stenosis. While the PTSMA relieved LVOT obstruction and symptoms in the acute phase, the modest recurrence was confirmed 6 months later, which is rare in the case of idiopathic HOCM. The possible mechanisms of LVOT obstruction and recurrence are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Elliott P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet. 2004;363:1881–91.

    Article  CAS  PubMed  Google Scholar 

  2. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol. 1981;48:418–28.

    Article  CAS  PubMed  Google Scholar 

  3. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Maria A, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. 2003;348:295–303.

    Article  PubMed  Google Scholar 

  4. Maron BJ. Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy. Circulation. 2007;116:196–206.

    Article  PubMed  Google Scholar 

  5. Rigopoulos AG, Seggewiss H. A decade of percutaneous septal ablation in hypertrophic cardiomyopathy. Circ J. 2011;75:28–37.

    Article  PubMed  Google Scholar 

  6. Lachman AS, Spray TL, Kerwin DM, Shugoll GI, Roberts WC. Medial calcinosis of Mönckeberg. A review of the problem and a description of a patient with involvement of peripheral, visceral and coronary arteries. Am J Med. 1977;63:615–22.

    Article  CAS  PubMed  Google Scholar 

  7. Kovacic JC, Moreno P, Nabel EG, Hachinski V, Fuster V. Cellular senescence, vascular disease, and aging part 2 of a 2-part review: clinical vascular disease in the elderly. Circulation. 2011;123:1900–10.

    Article  PubMed  Google Scholar 

  8. Topol EJ, Traill TA, Fortuin NJ. Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med. 1985;312:277–83.

    Article  CAS  PubMed  Google Scholar 

  9. Pearson AC, Gudipati CV, Labovitz AJ. Systolic and diastolic flow abnormalities in elderly patients with hypertensive hypertrophic cardiomyopathy. J Am Coll Cardiol. 1988;12:989–95.

    Article  CAS  PubMed  Google Scholar 

  10. Aurigemma G, Battista S, Orsinelli D, Sweeney A, Pape L, Cuenoud H. Abnormal left ventricular intracavitary flow acceleration in patients undergoing aortic valve replacement for aortic stenosis. A marker for high postoperative morbidity and mortality. Circulation. 1992;86:926–36.

    Article  CAS  PubMed  Google Scholar 

  11. Routledge T, Nashef SAM. Severe mitral systolic anterior motion complicating aortic valve replacement. Interact Cardiovasc Thorac Surg. 4;4:486–7.

    Article  Google Scholar 

  12. Mönckeberg JG: Uber die heine mediaverkalkung der extremitätenarterien und ihr verhalten zur arteriosklerose. Virchows Arch [Pathol Anat].1903;171:141–167.

    Article  Google Scholar 

  13. Lakkis NM, Nagueh SF, Dunn JK, Killip D, Spencer WH 3rd. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up. J Am Coll Cardiol. 2000;36:852–5.

    Article  CAS  PubMed  Google Scholar 

  14. Mazur W, Nagueh SF, Lakkis NM, Middleton KJ, Killip D, Roberts R, et al. Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation. 2001;103:1492–6.

    Article  CAS  PubMed  Google Scholar 

  15. Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol. 1998;31:252–8.

    Article  CAS  PubMed  Google Scholar 

  16. Faber L, Meissner A, Ziemssen P, Seggewiss H. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients. Heart. 2000;83:326–31.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Tsuchikane E, Takeda Y, Kobayashi T, Yachiku K, Nasu K, Kobayashi Y, et al. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy initial and follow-up results in the first 27 patients. Circ J. 2003;67:763–7.

    Article  PubMed  Google Scholar 

  18. van Dockum WG, Beek AM, ten Cate FJ, ten Berg JM, Bondarenko O, Götte MJ, et al. Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation. 2005;111:2503–8.

    Article  PubMed  Google Scholar 

  19. Veselka J, Duchonová R, Páleníckova J, Zemánek D, Tiserová M, Linhartová K, et al. Impact of ethanol dosing on the long-term outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy: a single-center prospective, and randomized study. Circ J. 2006;70:1550–2.

    Article  PubMed  Google Scholar 

  20. Geske JB, Sorajja P, Ommen SR, Nishimura RA. Left ventricular outflow tract gradient variability in hypertrophic cardiomyopathy. Clin Cardiol. 2009;32:397–402.

    Article  PubMed  Google Scholar 

  21. Geske JB, Sorajja P, Ommen SR, Nishimura RA. Variability of left ventricular outflow tract gradient during cardiac catheterization in patients with hypertrophic cardiomyopathy. JACC Cardiovasc Interv. 2011;4:704–9.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are indebted to Asuka Sato for secretarial assistance and to Shigeru Mizusaki for manuscript preparation.

Conflict of interest

There is no conflict of interest of authors.

Author information

Authors and Affiliations

  1. Division of Cardiology, Mie Heart Center, 2227-1, Ohyodo, Meiwa, Takigun, Mie, 515-0302, Japan

    Masafumi Kato, Masatoshi Miyahara, Hiroyuki Suzuki & Hideo Nishikawa

  2. Division of Clinical Laboratory, Mie Heart Center, 2227-1, Ohyodo, Meiwa, Takigun, Mie, 515-0302, Japan

    Fumiya Uchida

  3. Division of Cardiovascular Surgery, Mie Heart Center, 2227-1, Ohyodo, Meiwa, Takigun, Mie, 515-0302, Japan

    Yoshiyuki Nishimura

Authors
  1. Masafumi Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masatoshi Miyahara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiroyuki Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fumiya Uchida
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yoshiyuki Nishimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hideo Nishikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masafumi Kato.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kato, M., Miyahara, M., Suzuki, H. et al. A case of successful percutaneous transluminal septal myocardial ablation for heart failure due to severe left ventricular outflow obstruction with Mönckeberg’s arteriosclerosis, manifested after aortic valvular replacement. Cardiovasc Interv and Ther 30, 72–77 (2015). https://doi.org/10.1007/s12928-014-0252-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12928-014-0252-x

Keywords

Search

Navigation